Latest action: Referred to the House Committee on Energy and Commerce.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Protects community health centers from high drug prices.
The problem
Community health centers struggle to afford medications for patients due to rising drug costs, limiting care access for low-income populations.
The proposal
The bill restricts drug pricing practices that burden community health centers, likely requiring price transparency or negotiation protections for these facilities.
The impact
Community health centers, low-income patients, and pharmaceutical companies are affected. Centers gain pricing relief; patients access cheaper care; drugmakers face pricing limits.
Community health centers serve uninsured and low-income people. Lower drug prices mean these patients can afford medications they need. This improves health outcomes for vulnerable populations.
Health centers spend significant budgets on medications. Price protections reduce operating expenses. Centers can invest savings into hiring staff and expanding services.
When drug costs are predictable, centers can budget effectively and maintain consistent medication availability. Patients receive reliable care without supply gaps.
Pharmaceutical companies invest profits into developing new medicines. Price controls reduce their revenue, potentially slowing research into new treatments and cures.
If prices are too restricted, drugmakers might stop producing certain medications or reduce supply. This could create shortages affecting all patients, not just community centers.
If one group gets price breaks, companies might raise prices for other customers. Insurance companies and other hospitals could pay more to offset losses.
New pricing rules require government oversight and enforcement. This increases bureaucracy and administrative costs that taxpayers fund.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.